So excited to share our commentary out now in LancetCAH and freely available via the link below! The time is NOW for Adaptive Platform Trials to improve outcomes for preterm infants! @platipus.bsky.social url.au.m.mimecastprotect.com/s/ukzLCmOxr6...

We're pleased to share our first animation, that aims to grow potential participant awareness of PLATIPUS and how it works. Special thanks to Stephanie Hebbard, Kelly Fredell, Tara Lofhelm, PLATIPUS Lived Experience Committee and others who helped create this. www.platipustrial.org/participants...

Have you read our article about adaptive platform trials for preterm birth yet? #neosky We discuss the challenges facing perinatal clinical researchers and how traditional RCTs may no longer be fit for purpose in our field. Are APTs the answer? www.thelancet.com/journals/lan...

Cytomegalovirus (CMV) is the leading cause of infectious birth defects and linked to many other morbidities such as with transplantation. For the first time after >50 years of pursuit, a vaccine is in reach jci.org/articles/vie...

Such a huge amount of work - the PLUSS trial published in JAMA by our own @drbretty.bsky.social

Exciting times ahead leading the PLATIPUS trial with @drbretty.bsky.social Follow us or @platipus.bsky.social for updates on the PLATIPUS & its first 2 domains: 1. PROMOAT - best choice of ABx for PPROM 2. BabyCCINO - which caffeine citrate dose for very preterm infants #NeoSky #NICUSky #ObGynSky

Great to see progress in stillbirth reduction - but so much still to be done www.thelancet.com/journals/lan...

Well done Robyn and Della. It’s so important we maintain a skilled midwifery workforce to keep our patients safe and optimise outcomes.